Ulcerative Colitis Clinical Trials in Houston

Showing 581-598 of 598 trials

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD

NCT00648245

The symptoms associated with COPD include overproduction of mucus and inflammation in the lungs. Overproduction of mucus results in impaired lung function and it encourages bacterial growth and associated COPD exacerbations. Therefore, a treatment that inhibits mucus overproduction or blocks inflammation could benefit COPD patients. The drug under evaluation in this study, BIO-11006 Inhalation Solution, is a new drug that may inhibit overproduction of mucus and may have important anti-inflammatory properties.

COPDChronic Obstructive Pulmonary Disease

BioMarck Pharmaceuticals, Ltd.172 participantsStarted Jun 2008

Glendale, Arizona, United States • Los Angeles, California, United States • Bay Pines, Florida, United States +11 more locations

TERMINATEDPhase 3< 1 mile

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

NCT00138671

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Chronic Obstructive Pulmonary Disease.

Diabetes MellitusChronic Obstructive Pulmonary Disease

Pfizer105 participantsStarted Jan 2003

Glendale, Arizona, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +85 more locations

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Ulcerative Colitis Trials in Other Cities

Quality of Life in Pediatric Inflammatory Bowel Disease

Transforming Psychotherapy for Chronically Ill Patients

Basiliximab in Moderate to Severe Ulcerative Colitis

Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community

Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Other Conditions in Houston